Evaluating the effect of black myrobalan fruit (Terminalia Chebula Retz.) on cognitive impairments, and positive and negative symptoms in patients with chronic schizophrenia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110310006026N7

Enrollment

Registered

2018-04-07

Start date

2018-05-01

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group: Powdered black myrobalan fruit with almond oil (10% w/w) are administered as three 500 mg capsule twice daily for four weeks. Intervention 2: Control group: starch

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Hospitalized patients with chronic schizophrenia based on DSM-IV criteria Having no significant change in medication or symptoms over the previous 2 months

Exclusion criteria

Exclusion criteria: Mental retardation Substance dependence History of significant medical illness

Design outcomes

Primary

Measure	Time frame
Cognitive functions. Timepoint: At baseline and 4 weeks after intervention. Method of measurement: Screen for Cognitive Impairment in Psychiatry (SCIP) questionnaire.;Positive and negative symptoms. Timepoint: At baseline and 4 weeks after intervention. Method of measurement: Positive and Negative Syndrome Scale (PANSS) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Dabaghzadeh

Kerman University of Medical Sciences

fatemeh_dabaghzadeh@yahoo.com+98 34 3132 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026